Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laparoscopy for Assessing Hepatic Metastasis

By HospiMedica staff writers
Posted on 01 Sep 2005
Researchers have reported that laparoscopy with intraoperative ultrasound is a valuable method of evaluating and managing isolated hepatic metastasis from colorectal cancer by identifying inoperable patients and by treating patients without laparotomy. More...


Laparoscopic assessment of the liver can be an important staging and treatment method for the management of patients with colorectal cancer patients with apparent isolated metastases to the liver.

The investigators, from the departments of hepatobiliary and pancreatic surgery and minimally invasive surgery, Legacy Health System (Portland, OR, USA), tried to determine the specific benefit of laparoscopy when combined with intraoperative ultrasound in the assessment and treatment of 152 patients who had isolated hepatic metastasis as determined by computed tomography (CT) and by positron emission tomography (PET), which was conducted in 70% of the cases.

The researchers discovered surgically untreatable disease in 25% of patients because of peritoneal metastasis, nodal involvement, diffuse hepatic disease, or untreatable disease. Furthermore, two patients had no identifiable disease at laparoscopy. Laparoscopic treatment included radiofrequency ablations, hepatic artery implantations, resections, and combined procedures. The researchers reported that laparoscopy with intraoperative sonography altered the treatment plans of about 50% of patients in relation to preoperative plans. Complication rates were seen in just three patients who had a median hospital stay of one day. The study also showed that many patients with isolated hepatic metastasis can be treated without the invasiveness of a laparotomy procedure.

The study was published in the August 8, 2005, issue of the journal Archives of Surgery.




Related Links:
Legacy Health Systems

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.